Vancomycin in Primary Sclerosing Cholangitis in Italy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Vancomycin in Primary Sclerosing Cholangitis in Italy — Stella

Recruiting

Back to Primary Sclerosing Cholangitis trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Italy

Fondazione IRCCS San Gerardo dei Tintori, Monza, Monza E Brianza

Key details

Phase

Safety & dosing

Sponsor

University of Milano Bicocca

Collaborators

Genetic s.p.a.

Enrollment target

~84 participants

Started

June 2023

Primary completion

June 2026

Age range

15 Years – 70 Years

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov